BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16841035)

  • 1. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.
    de Haas ER; Kruijt B; Sterenborg HJ; Martino Neumann HA; Robinson DJ
    J Invest Dermatol; 2006 Dec; 126(12):2679-86. PubMed ID: 16841035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
    de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
    Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up.
    Star WM; van't Veen AJ; Robinson DJ; Munte K; de Haas ER; Sterenborg HJ
    Acta Derm Venereol; 2006; 86(5):412-7. PubMed ID: 16955185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
    Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
    J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
    Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
    Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
    Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
    Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a single day patient friendly methyl aminolevulinate photodynamic therapy illumination scheme for superficial basal cell carcinoma feasible? A randomized multicenter pilot trial.
    Nguyen KP; Knuiman GJ; Blokx WAM; Hoogedoorn L; Smits T; Gerritsen MJP
    J Dermatolog Treat; 2019 Mar; 30(2):194-199. PubMed ID: 29862877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical photodynamic therapy at low fluence rates--theory and practice.
    Langmack K; Mehta R; Twyman P; Norris P
    J Photochem Photobiol B; 2001 Apr; 60(1):37-43. PubMed ID: 11386679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
    Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
    Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.
    Zeitouni NC; Sunar U; Rohrbach DJ; Paquette AD; Bellnier DA; Shi Y; Wilding G; Foster TH; Henderson BW
    Dermatol Surg; 2014 Dec; 40(12):1390-4. PubMed ID: 25393353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
    Sotiriou E; Apalla Z; Chovarda E; Goussi C; Trigoni A; Ioannides D
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):36-40. PubMed ID: 21366709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
    Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
    Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
    Griškjans Ž; Derjabo A; Čēma I
    Stomatologija; 2013; 15(1):32-6. PubMed ID: 23732828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.
    Mosterd K; Thissen MR; Nelemans P; Kelleners-Smeets NW; Janssen RL; Broekhof KG; Neumann HA; Steijlen PM; Kuijpers DI
    Br J Dermatol; 2008 Sep; 159(4):864-70. PubMed ID: 18717680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.